Clinical Trials Browser

UNKNOWN × Leiomyosarcoma × Temozolomide × Clear all

NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

Phase NA Unknown

Leiomyosarcoma